Price Chart

Profile

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
URL http://www.delcath.com
Investor Relations URL http://delcath.com/investors/
HQ State/Province New York
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release Mar. 05, 2026 (est.)
Last Earnings Release Nov. 04, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
URL http://www.delcath.com
Investor Relations URL http://delcath.com/investors/
HQ State/Province New York
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release Mar. 05, 2026 (est.)
Last Earnings Release Nov. 04, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A